EFPIA - NEWSLETTER

EFPIA Newsletter 16 September 2021

News

16 September 2020 EFPIA Statement on the State of the Union Address

The COVID-19 crisis has underlined the importance of Europe’s health research eco-system, our resilience to health threats,...

Blogs

Recordings of the PIONEERing Webinar

Estimands in Clinical Research

Bringing estimands to life through a real case study. A year on after the final ICH E9 estimands addendum was published, we bring estimands to life from a real example from protocol to press release. Members of the estimands Implementation Working Group (EIWG) will describe the background and study objectives, intercurrent events of interest and chosen estimands in the PIONEER study.

Estimands in Oncology - How and Why

You will be guided through a case study (CheckMate 037) and interactively deepen the knowledge to gain hands-on experience in developing estimands.

Events

European Alliance for Value in Health

It is time to reshape the health system from the rubble, aligning efforts to value
15 Sep 2021
A blog by Giovanni Gorgoni, Chair at EUREGHA & CEO at AReSS Puglia

It is pretty easy to say “value” in healthcare and quite hard to actually practice it in processes and services. This is why we often see so many conferences on VBHC and less long-lasting experiences. Read more...

What we are reading

Innovate and Adapt the Regulatory System 15 September 2021 (Pfizer)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶